Skip to content

Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial

Quadriceps Tendon Autograft, Tendon-Bone Versus All-Soft-Tissue for Anterior Cruciate Ligament Reconstruction: A Patient-Blinded Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04039971
Enrollment
150
Registered
2019-07-31
Start date
2020-08-01
Completion date
2029-08-31
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear

Keywords

ACL, ACL Tear, ACL Injury, ACL Rupture, Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament, ACL Repair, ACL Reconstruction, ACL Surgery, Anterior Cruciate Ligament Repair, Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Surgery

Brief summary

In primary pediatric Anterior cruciate ligament (ACL) reconstruction, the quadriceps tendon with either tendon and patellar bone or an all-tendon graft is commonly employed. However, no randomized control trial has sought to discern the superior graft option in regards to both short-term and long-term patient outcomes.The purpose of this study is to assess the differences between these two widely used surgical techniques in ACL reconstruction by examining short, intermediate, and long term outcomes of both approaches.

Detailed description

It is well known that ACL injuries are among the most common sports and knee injuries. As a result, ACL reconstruction is at the forefront both in terms of research and development and advancements in technique. One focus of research is graft choice and the risks and benefits associated with each. There are multiple valid graft choices including bone-patellar tendon-bone, hamstring tendon, quadriceps tendon, quadriceps tendon-patellar bone, and allograft. Graft choice is often patient centered and based on both patient and surgeon considerations such as age, sex, activity level, surgeon preference and graft associated complications. The present study seeks to compare the intraoperative, immediate perioperative, intermediate and long-term outcomes between tendon-bone and all-soft-tissue quadriceps tendon autograft in ACL reconstruction in adolescent patients. The investigators will analyze data on operative time, cost, complications, recovery of strength and range of motion, return to sports rates, patient reported outcomes, and failure rates. With this proposal the investigators hope to determine if there is a superior graft technique in this population. Both graft types are validated in the literature separately as options for ACL reconstruction in this age group. There has been no clinical research comparing the two graft types, and therefore no consensus is made among surgeons on whether to use tendon-bone or all-soft-tissue when it comes to the QT autograft. A secondary aim of this study is to obtain patient reported outcomes throughout the post-operative period to determine if the patient experience is different between the two graft types. This data may be used in guiding a surgeon's decision on which type to use with their patients.

Interventions

PROCEDUREACL Reconstruction

Surgical techniques

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Children's Hospital Colorado
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Males and females * Patients ages 12 to 19 (inclusive) * Patients undergoing primary ACL reconstruction

Exclusion criteria

* Patients with an underlying neuromuscular diagnosis or neurological injury * Patients with lower extremity fractures, dislocations, or multi-ligamentous injuries, which required surgery, concurrent with or occurring two years or less prior to primary ACL injury. * Patients with an underlying systemic or musculoskeletal diagnosis

Design outcomes

Primary

MeasureTime frameDescription
Short-Term Graft Superiority1 to 2 yearsGraft superiority will be evaluated by the time to return to sports and the length of return to sports.
Long-Term Graft Superiority5 yearsLong-term graft superiority will be evaluated by graft failure rate or ACL re-rupture.

Secondary

MeasureTime frameDescription
Patient Reported OutcomesPre-operative appointment, 3 months, 6 months, 12 months, 24 months, and 5 years post-operative appointmentsPatients will complete a survey at specific time points to gauge knee function throughout treatment.
Time to Return to Sports RatesAs recorded in post-operative physical therapy visits (approx. 6 months to 1 year)Time to return to sports will be evaluated based on physical therapy milestones related to return to sports clearance.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORStephanie Mayer, MD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026